Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma

ObjectivesAnti-PD-(L)1 agents changed the landscape of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treatment. Previous studies showed improved response rates to salvage chemotherapy (SCT) after progression to anti-PD-(L)1 agents. This study aims to evaluate the outcomes...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Llop, Maria Plana, Sara Tous, Angelica Ferrando-Díez, Jesús Brenes, Marc Juarez, Zara Vidales, Esther Vilajosana, Isabel Linares, Lorena Arribas, Maria Duch, Marta Fulla, Aina Brunet, Alicia Lozano, Beatriz Cirauqui, Ricard Mesía, Marc Oliva
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
head and neck
squamous cell carcinoma
HNSCC
immunotherapy
anti-PD-(L)1
salvage chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1458479/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items